JNJ and LLY Related Headlines
Go Back- Leerink highlights drug demand rebound after Memorial Day
- Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight
- Goldman Sachs: 'top themes we're tracking for 2026'
- Trump to announce prescription drug price agreements
- Biotech Valuations Rise as New Clinical Platforms Show Progress
- Vida Ventures Marks Fourth Major Portfolio Acquisition in 2025, Capping a Record-Setting Year for Its Science-Led, Discipline-Driven Strategy
JNJ and LLY Related Press Releases
Go Back- Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight
- Biotech Valuations Rise as New Clinical Platforms Show Progress
- Vida Ventures Marks Fourth Major Portfolio Acquisition in 2025, Capping a Record-Setting Year for Its Science-Led, Discipline-Driven Strategy
